
Click link below picture
.
Six days before Austin Pledger swallowed his first Risperdal, Janssen scientists and marketing executives met with an advisory board of doctors in a luxury hotel suite in New York. The group wrestled with problems concerning the prolactin and gynecomastia data that had come in from the clinical study Gorsky and his team had ordered up, hoping to put the issue to rest.
This new study was actually a study of studies. It pooled the one study called “INT-41”—which had the largest number of participants and the worst results and had devoted what those who conducted it called “special attention to prolactin”—with four smaller, more general studies that had produced less troubling numbers.
Although this approach diluted the bad news for Janssen, there were still two problems.
.
Risperdal
.
.
Click link below for article:
http://highline.huffingtonpost.com/miracleindustry/americas-most-admired-lawbreaker/chapter-5.html
.
__________________________________________
Leave a comment